Skip to main content
Equibles

FIRST TRUST ADVISORS LP

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1125816 Wheaton, IL
Back to SUPN Full portfolio

Position in SUPN

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$6,521,027
+$4,110,878 QoQ
Shares Held
140,207
+200.7% QoQ
Ownership
0.241%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 335 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

FIRST TRUST ADVISORS LP holds $670,557,120 across 30 Drug Manufacturers - Specialty & Generic names. SUPN ranks #12 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 923,125 $155,583,487
2 UTHR
UNITED THERAPEUTICS Corp
 249,056 $134,946,012
3 ALKS
Alkermes plc.
 2,421,016 $126,861,238
4 ZTS
Zoetis Inc.
 1,435,652 $103,165,952
5 TAK
Takeda Pharmaceutical Co Ltd
 2,114,912 $33,902,039
6 LQDA
Liquidia Corp
 301,432 $24,033,173
7 BCRX
Biocryst Pharmaceuticals Inc
 1,120,469 $11,204,690
8 AMRX
Amneal Pharmaceuticals, Inc.
 614,206 $10,631,905

All Filings in SUPN

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,521,027 140,207
2026-03-31 $2,410,149 46,627
2025-12-31 $1,481,258 29,804
2025-09-30 $3,386,303 70,858
2025-06-30 $2,808,085 89,089
2025-03-31 $2,367,759 72,298
2024-12-31 $977,007 27,019
2024-09-30 $1,623,449 52,067
2024-06-30 $574,937 21,493
2024-03-31 $1,732,446 50,790
2023-12-31 $1,593,783 55,072
2023-09-30 $1,412,769 51,243
2023-06-30 $1,048,222 34,871
2023-03-31 $563,050 15,541
2022-12-31 $526,845 14,770
2022-09-30 $2,051,005 60,591
2022-06-30 $1,914,851 66,212
2021-09-30 $2,939,754 110,227
2021-06-30 $6,203,815 201,488
2021-03-31 $2,175,400 83,094
2020-12-31 $1,975,563 78,520
2020-09-30 $1,302,249 62,488
2020-06-30 $1,410,631 59,395